JPMorgan Chase & Co. 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-06 08:37 am Sale | 2022-09-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | JPMORGAN CHASE & CO JPM | 1,491,001 2.700% | -1,608,568 (-51.90%) | Filing |
| 2022-01-19 12:37 pm Purchase | 2021-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | JPMORGAN CHASE & CO JPM | 3,099,569 5.700% | 3,099,569 (New Position) | Filing |